Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Frontotemporal dementia and/or amyotrophic lateral sclerosis 7

MONDO:0010936

Any amyotrophic lateral sclerosis in which the cause of the disease is a mutation in the CHMP2B gene.

Also known as: CHMP2B amyotrophic lateral sclerosis, CHMP2B-related amyotrophic lateral sclerosis, FTD3, amyotrophic lateral sclerosis caused by mutation in CHMP2B, amyotrophic lateral sclerosis, Chmp2B-related, frontotemporal dementia, chromosome 3-linked, Dmt1, dementia, familial nonspecific

30 clinical trials for this condition and its sub-types.

Follow this condition to get notified about new trials

Broader categories

Dementia (722) Disease (717) Psychiatric disorder (475) Cognitive disorder (441) Amyotrophic lateral sclerosis (318) Nervous system disorder (243) Hereditary disease (188) Neurodegenerative disease (182) Frontotemporal dementia (130) Central nervous system disorder (115)
Trials to join now! 19 Not yet recruiting 2 Not yet finished but already full! 5 Completed 3 Terminated 1
Sort by
  • Can a synthetic cannabinoid calm agitation in frontotemporal dementia?

    Symptom relief Stopped early

    This phase 2 trial tests whether nabilone, a synthetic cannabinoid, can reduce agitation in people with frontotemporal dementia (FTD). Participants receive both nabilone and a placebo in random order to compare effects. The study includes adults with behavioral variant FTD or pri…

    Phase 2 • Sponsor: Simon Ducharme, MD • Aim: Symptom relief

    Last updated Jul 30, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space